Can Cognitive Training Decrease Reactive Aggression?

NCT03623477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-02-28

No results posted yet for this study

Summary

The purpose of the study is to examine the effects of cognitive training on emotion regulation, impulse control, and aggression in people with schizophrenia. The study compares a combination of computerized cognitive remediation and social cognition training (CRT+SCT) to cognitive remediation alone (CRT). Study outcomes include multiple measures of aggression, emotion regulation, impulse control, cognition, and symptoms.

Conditions

Interventions

BEHAVIORAL

Cognitive Remediation (CRT)

Study compares two configurations of cognitive training--computerized cognitive remediation versus a combination of computerized cognitive remediation and social cognition training. The cognitive remediation therapy group will complete computerized training activities in attention, memory, processing speed, problem solving, and executive functions.

BEHAVIORAL

CRT+ Social Cognition Training

Study compares two configurations of cognitive training--computerized cognitive remediation versus a combination of computerized cognitive remediation and social cognition training. The combined cognitive remediation and social cognition training group will complete computerized training that target neurocognitive functions, facial affect emotion recognition and mentalizing tasks.

Sponsors & Collaborators

  • Brain & Behavior Research Foundation

    collaborator OTHER
  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH
  • Nathan Kline Institute for Psychiatric Research

    collaborator OTHER
  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Anthony O Ahmed, PhD · Weill Medical College of Cornell University

  • Jean-Pierre Lindenmayer, MD · Manhattan Psychiatric Center

  • Matthew J Hoptman, PhD · Nathan Kline Institute for Psychiatric Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-16
Primary Completion
2019-10-25
Completion
2019-10-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03623477 on ClinicalTrials.gov